Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1972 Apr;35(2):163–169. doi: 10.1136/jnnp.35.2.163

Conduction in unmyelinated fibres in experimental neuropathy1

A P Hopkins 1,2, E H Lambert 1
PMCID: PMC494030  PMID: 4338687

Abstract

Conduction velocity of autonomic unmyelinated fibres has been measured in the cervical sympathetic trunk of normal rats, and in rats intoxicated by acrylamide or by isoniazid. The mean maximal conduction velocity in nerves from normal rats is 2·0 m/sec. There is no significant reduction in velocity of the unmyelinated fibres in nerves from intoxicated rats, although histological studies of the sural nerve confirmed severe degeneration of myelinated fibres in the same animals. It is shown that the amplitude of the compound nerve action potential is proportional to the resistance between the recording electrodes. If this is taken into account, there is no reduction in the amplitude of the monophasic action potential of unmyelinated fibres recorded from the cervical sympathetic trunk of intoxicated rats. The amplitude of the A component of the sural nerve compound action potential is markedly reduced in rats intoxicated by acrylamide or by isoniazid, but there is no significant reduction in the amplitude of the C component in the same nerve. It is concluded that in the rat an insignificant number of unmyelinated fibres of autonomic or dorsal root origin are affected in the neuropathy produced by acrylamide or isoniazid. The relevance of these findings to human neuropathies is discussed.

Full text

PDF
163

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aguayo A. J., Nair C. P., Bray G. M. Peripheral nerve abnormalities in the Riley-Day syndrome. Findings in a sural nerve biopsy. Arch Neurol. 1971 Feb;24(2):106–116. doi: 10.1001/archneur.1971.00480320034003. [DOI] [PubMed] [Google Scholar]
  2. BARANY F. R., COOPER E. H. Pilomotor and sudomotor innervation in diabetes. Clin Sci. 1956 Nov;15(4):533–540. [PubMed] [Google Scholar]
  3. Dyck P. J., Lambert E. H. Dissociated sensation in amylidosis. Compound action potential, quantitative histologic and teased-fiber, and electron microscopic studies of sural nerve biopsies. Arch Neurol. 1969 May;20(5):490–507. doi: 10.1001/archneur.1969.00480110054005. [DOI] [PubMed] [Google Scholar]
  4. ELIASSON S. G. NERVE CONDUCTION CHANGES IN EXPERIMENTAL DIABETES. J Clin Invest. 1964 Dec;43:2353–2358. doi: 10.1172/JCI105109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fullerton P. M., Barnes J. M. Peripheral neuropathy in rats produced by acrylamide. Br J Ind Med. 1966 Jul;23(3):210–221. doi: 10.1136/oem.23.3.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fullerton P. M. Electrophysiological and histological observations on peripheral nerves in acrylamide poisoning in man. J Neurol Neurosurg Psychiatry. 1969 Jun;32(3):186–192. doi: 10.1136/jnnp.32.3.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hopkins A. P., Gilliatt R. W. Motor and sensory nerve conduction velocity in the baboon: normal values and changes during acrylamide neuropathy. J Neurol Neurosurg Psychiatry. 1971 Aug;34(4):415–426. doi: 10.1136/jnnp.34.4.415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hopkins A. The effect of acrylamide on the peripheral nervous system of the baboon. J Neurol Neurosurg Psychiatry. 1970 Dec;33(6):805–816. doi: 10.1136/jnnp.33.6.805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. JONES W. A., JONES G. P. Peripheral neuropathy due to isoniazid; report of two cases. Lancet. 1953 May 30;1(6770):1073–1074. doi: 10.1016/s0140-6736(53)92204-1. [DOI] [PubMed] [Google Scholar]
  10. Ochoa J. Isoniazid neuropathy in man: quantitative electron microscope study. Brain. 1970;93(4):831–850. doi: 10.1093/brain/93.4.831. [DOI] [PubMed] [Google Scholar]
  11. Ochoa J., Mair W. G. The normal sural nerve in man. I. Ultrastructure and numbers of fibres and cells. Acta Neuropathol. 1969;13(3):197–216. doi: 10.1007/BF00690642. [DOI] [PubMed] [Google Scholar]
  12. Ochoa J., Mair W. G. The normal sural nerve in man. II. Changes in the axons and Schwann cells due to ageing. Acta Neuropathol. 1969;13(3):217–239. doi: 10.1007/BF00690643. [DOI] [PubMed] [Google Scholar]
  13. Pleasure D. E., Mishler K. C., Engel W. K. Axonal transport of proteins in experimental neuropathies. Science. 1969 Oct 24;166(3904):524–525. doi: 10.1126/science.166.3904.524. [DOI] [PubMed] [Google Scholar]
  14. Prineas J. The pathogenesis of dying-back polyneuropathies. II. An ultrastructural study of experimental acrylamide intoxication in the cat. J Neuropathol Exp Neurol. 1969 Oct;28(4):598–621. doi: 10.1097/00005072-196910000-00004. [DOI] [PubMed] [Google Scholar]
  15. SCHLAEPFER W. W., HAGER H. ULTRASTRUCTURAL STUDIES OF INH-INDUCED NEUROPATHY IN RATS. 3. REPAIR AND REGENERATION. Am J Pathol. 1964 Oct;45:679–689. [PMC free article] [PubMed] [Google Scholar]
  16. SCHLAEPFER W. W., HAGER H. ULTRASTRUCTURAL STUDIES OF INH-INDUCED NEUROPATHY IN RATS. II. ALTERATION AND DECOMPOSITION OF THE MYELIN SHEATH. Am J Pathol. 1964 Sep;45:423–433. [PMC free article] [PubMed] [Google Scholar]
  17. Schröder J. M. Die Feinstruktur markloser(Remakscher) Nervenfasern bei der Isoniazid-Neuropathie. Acta Neuropathol. 1970;15(2):156–175. doi: 10.1007/BF00685268. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES